Todd E. Simpson, Chief Financial Officer at SEATTLE GENETICS INC /WA (SGEN), sold 15,000 shares at $85.00 ($1.3M) on 2019-09-30, disclosed to the SEC on 2019-10-02.
Open-market sale of $1.3M SGEN by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| SGEN | SELL | 2023-08-30 | $100K | — | Filing → |
| SGEN | SELL | 2023-04-12 | $22.6M | — | Filing → |
| SGEN | SELL | 2023-04-07 | $100K | — | Filing → |